2013/2014 KAN-BIO_GCC Governance, Control and Contracts in BioBusiness
English Title | |
Governance, Control and Contracts in BioBusiness |
Course information |
|
Language | English |
Exam ECTS | 7.5 ECTS |
Type | Mandatory |
Level | Full Degree Master |
Duration | One Semester |
Course period | Autumn |
Time Table | Please see course schedule at e-Campus |
Max. participants | 10 |
Study board |
Study Board for MSc. in Business Administration and
Bioentrepreneurship
|
Course coordinator | |
|
|
Several factors
necessitate size restrictions for this course to max. 10 students.
CBS students have to apply through the official CBS course enrollment and credit students must apply by filling out an application form found at www.cbs.dk. |
|
Main academic disciplines | |
|
|
Last updated on 12-02-2013 |
Learning objectives | |||||||||||||||||||||
The course enables students to
analyze how their internal operations and external relationships
can be managed, governed and made subject to contracting in an
environment characterized by high uncertainty and where the
development of the firm is dependent on both creative processes and
the ability to handle relationships to stakeholders such as venture
capitalists, suppliers and customers. Students learn to design
appropriate solutions for controlling innovation and product
development and to identify, analyze and account for basic legal
problems in contracts. They become capable at identifying
opportunities and pitfalls of different contractual, control and
governance mechanisms, to understand how they change over the
life-cycle of the firm, and to use the acquired knowledge to build
and successfully develop innovative enterprises.
To achieve 12, as the course’s final grade, the student must perform the following: • Apply relevant theories of contracting, governance and control to managerial problems in both entrepreneurial and established firms in the biotech/pharma sector. • Analyze how firms’ internal operations and external relationships can be managed, governed and made subject to contracting. • Discuss appropriate structures for controlling, contracting and governing innovation and product development. |
|||||||||||||||||||||
Course prerequisites | |||||||||||||||||||||
Students must have completed the first year in one of the following cand.merc. programmes: FIR, FSM, ASC, AEF, IMM, IBS, MIB. | |||||||||||||||||||||
Examination | |||||||||||||||||||||
|
|||||||||||||||||||||
Course content and structure | |||||||||||||||||||||
Bio ventures rely heavily on strategic relationships to external
stakeholders such as large costumer organizations (e.g. global
pharmaceutical firms), partners for out-sourced R&D, suppliers
of venture capital etc. At the same time their internal operations
(largely research) are difficult to manage and control by
conventional approaches. These characteristic tie together a set of
closely related issues in governance, control and contracting. This
course addresses these interdependent issues by teaching key
concepts and tools within each of three issues as well as their
interdependencies are discussed.
|
|||||||||||||||||||||
Teaching methods | |||||||||||||||||||||
The course will mix lectures with casework and simulations. Guest faculty from industry will frequently appear in co‐teaching with academic faculty. | |||||||||||||||||||||
Further Information | |||||||||||||||||||||
Course teachers: Sof Thrane (lector), Aleksandra Gregorič(lector), Bjørn Lundqvist (lector) and guest teachers from industry. | |||||||||||||||||||||
Expected literature | |||||||||||||||||||||
Recommended literature:
|